Related Experiment Video
Updated: May 9, 2025
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
The Emerging Roles of Resolvins: Potential Diagnostic Biomarkers for Cardiovascular Diseases
Reyhan Bolat1, Burak Yazgan1,2
1Department of Biotechnology, Institute of Science, University of Amasya, Amasya, 05100, Turkey.
Insights
Resolvins, inflammation-resolving mediators, show promise as novel biomarkers for cardiovascular diseases (CVDs). Research explores their diagnostic and prognostic potential to improve early detection and patient outcomes.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiology
Background:
- Cardiovascular diseases (CVDs) are a leading global cause of mortality.
- Early diagnosis and improved survival rates for CVDs are critical research priorities.
- Specialized pro-resolving mediators, including resolvins, are gaining attention for their therapeutic and diagnostic potential.
Purpose of the Study:
- To evaluate the potential of resolvins as biomarkers for cardiovascular disease diagnosis and prognosis.
- To synthesize current knowledge on resolvin production pathways and their role in CVDs.
- To highlight the clinical relevance of altered resolvin levels in cardiovascular pathophysiology.
Main Methods:
- Literature review synthesizing existing research on resolvins.
- Analysis of biochemical pathways involved in resolvin synthesis (LOX, COX, CYP).
- Examination of precursor molecules (DHA, EPA, DPA) in resolvin production.
Main Results:
- Resolvins possess anti-inflammatory and tissue-healing properties.
- Specific resolvin series (D, T, E) are derived from omega-3 fatty acids.
- Altered levels of resolvins are implicated in the mechanisms of cardiovascular diseases.
Conclusions:
- Resolvins represent a promising area for developing novel biomarkers for CVDs.
- Understanding resolvin pathways and receptors is key to their clinical application.
- Further research into resolvins could offer new diagnostic and prognostic tools for cardiovascular conditions.
Abstract:
Cardiovascular diseases (CVDs) are the leading cause of death worldwide and include a range of conditions affecting the heart and vascular system. There is a growing priority on identifying and validating biomarkers for CVDs to increase early diagnosis and survival rates. Within this framework of research, there has been a notable increase in interest in resolvins, a class of specialized pro-resolving mediators. Resolvins are well-known for their capacity to promote tissue healing and reduce inflammation. They are categorized into three series: Dseries (RvD1 to RvD6), T-series (RvT1 to RvT4), and E-series (RvE1 to RvE4). These molecules are produced through biochemical pathways involving enzymes such as lipoxygenase (LOX), cyclooxygenase (COX), and cytochrome P450 (CYP). These enzymes utilize precursor molecules like docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and docosapentaenoic acid (DPA). This review addresses a critical gap in the literature by evaluating the potential of resolvins as biomarkers for the diagnosis and prognosis of cardiovascular diseases. By synthesizing existing knowledge on their production pathways and receptors, it highlights the implications of altered resolvins levels in disease mechanisms and offers new perspectives on their clinical relevance.
More Related Videos
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:31Internal Receptors
01:20Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:20Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...